Cardiovate is a medical device firm focused on developing tissue-engineering scaffold for aneurysm repair or “TESAR”. TESAR creates a tissue barrier between the blood and the aneurysm after it is implanted. The goal is to significantly reduce the need for secondary visits to the doctor and lower lifetime costs for patients who are treated with aneurysms. Cardiovate was formed out of UT San Antonio and UT Health Science Center San Antonio and received funding from the 2012 UT Horizon Fund Student Investment Competition.
Copyright © 2012 UT Horizon Fund – All Rights Reserved